Jan 20, 2022 | Featured, Medicare Part D, Statements
WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement regarding the Department of Health and Human Services’ new report on prescription drug affordability for Medicare Part D patients: “Action must be taken to make...
Read more
May 25, 2021 | Federal Issues, Medicare Part D
By Surabhi Dangi-Garimella, PhD Opinions vary on the impact H.R.3 would have on patients and the U.S. health care system as a whole, depending on who you ask. Some of the changes proposed by H.R.3 are directed to redesign the Medicare Part D prescription drug...
Read more
Jan 20, 2021 | Featured, Medicare Part D
By Surabhi Dangi-Garimella, Ph.D. Prescription drugs can be expensive, and for patients undergoing treatment for certain chronic conditions, cost-sharing is a heavy financial burden, especially if you are a Medicare beneficiary on a fixed income. While bills...
Read more
Nov 19, 2019 | Medicare Part D, Op-Ed
By Terry Wilcox Executive Director, Patients Rising Better health care was the top concern for 41 percent of voters in the midterm elections but Congress does not have to wait until next year to pass bipartisan health legislation. Among the must-pass bills for the...
Read more
Aug 6, 2019 | Drug Costs, Medicare Part D, News
Divided government, as a result of Democrats taking back the House of Representatives in last week’s election, means that almost all legislation will grind to a halt. This is especially true in today’s era of political polarization. But there is one Democratic policy...
Read more
Aug 6, 2019 | Medicare Part D, News
Better health care was the top concern for 41 percent of voters in the midterm elections, but Congress does not have to wait until next year to pass bipartisan health legislation. Among the must-pass bills for the 2018 lame duck session should be legislation that...
Read more
